

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.25940456 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.73023927 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.73023927 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.45487198 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.36695872 |
| 6 | interferon-gamma production (GO:0032609) | 4.35517213 |
| 7 | detection of other organism (GO:0098543) | 4.21258421 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.17970323 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.16320481 |
| 10 | detection of bacterium (GO:0016045) | 4.00332575 |
| 11 | negative regulation of cell killing (GO:0031342) | 3.95712796 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.95712796 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94427046 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.90728676 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.88256967 |
| 16 | leukocyte aggregation (GO:0070486) | 3.80407492 |
| 17 | positive thymic T cell selection (GO:0045059) | 3.73680867 |
| 18 | negative T cell selection (GO:0043383) | 3.63275900 |
| 19 | negative thymic T cell selection (GO:0045060) | 3.58609304 |
| 20 | detection of external biotic stimulus (GO:0098581) | 3.54717524 |
| 21 | T cell migration (GO:0072678) | 3.53229676 |
| 22 | regulation of B cell differentiation (GO:0045577) | 3.51874028 |
| 23 | negative regulation of phagocytosis (GO:0050765) | 3.50965695 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.48521821 |
| 25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.46118929 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 3.44106883 |
| 27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.42922497 |
| 28 | germinal center formation (GO:0002467) | 3.42663828 |
| 29 | response to host immune response (GO:0052572) | 3.40811244 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.40811244 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 3.39918403 |
| 32 | response to host (GO:0075136) | 3.36364539 |
| 33 | response to host defenses (GO:0052200) | 3.36364539 |
| 34 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.36364539 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.34952053 |
| 36 | tolerance induction (GO:0002507) | 3.31647785 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 3.30022927 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.27860666 |
| 39 | thymic T cell selection (GO:0045061) | 3.23959289 |
| 40 | negative regulation of T cell mediated immunity (GO:0002710) | 3.19705922 |
| 41 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.16315164 |
| 42 | regulation of leukocyte degranulation (GO:0043300) | 3.16242186 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.14822660 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.14822660 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 3.14822660 |
| 46 | positive regulation by symbiont of host defense response (GO:0052509) | 3.14822660 |
| 47 | modulation by symbiont of host defense response (GO:0052031) | 3.14822660 |
| 48 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.14822660 |
| 49 | T cell selection (GO:0045058) | 3.14394861 |
| 50 | detection of biotic stimulus (GO:0009595) | 3.14377084 |
| 51 | positive regulation of isotype switching (GO:0045830) | 3.13818046 |
| 52 | response to interleukin-15 (GO:0070672) | 3.12046300 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11681767 |
| 54 | natural killer cell differentiation (GO:0001779) | 3.08044923 |
| 55 | positive T cell selection (GO:0043368) | 3.06914365 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.03804674 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02423515 |
| 58 | cellular extravasation (GO:0045123) | 3.00368572 |
| 59 | positive regulation of histone deacetylation (GO:0031065) | 2.99997989 |
| 60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.97759766 |
| 61 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.97084671 |
| 62 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95794272 |
| 63 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.95617284 |
| 64 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.95229801 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.95061080 |
| 66 | macrophage activation (GO:0042116) | 2.94769415 |
| 67 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93651411 |
| 68 | defense response to protozoan (GO:0042832) | 2.92442548 |
| 69 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.92294943 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 2.90696486 |
| 71 | regulation of tolerance induction (GO:0002643) | 2.89240011 |
| 72 | leukocyte cell-cell adhesion (GO:0007159) | 2.88823740 |
| 73 | negative regulation of interleukin-12 production (GO:0032695) | 2.85778109 |
| 74 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.84735547 |
| 75 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.82194675 |
| 76 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80754085 |
| 77 | neutrophil activation (GO:0042119) | 2.80567559 |
| 78 | positive regulation of interleukin-2 production (GO:0032743) | 2.79454868 |
| 79 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.78780070 |
| 80 | hepatocyte apoptotic process (GO:0097284) | 2.78127119 |
| 81 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.77892748 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 2.76645736 |
| 83 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.75985026 |
| 84 | T-helper 1 type immune response (GO:0042088) | 2.72536596 |
| 85 | positive regulation of protein deacetylation (GO:0090312) | 2.72515412 |
| 86 | response to laminar fluid shear stress (GO:0034616) | 2.72269019 |
| 87 | T cell costimulation (GO:0031295) | 2.71389674 |
| 88 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70702747 |
| 89 | response to peptidoglycan (GO:0032494) | 2.70633414 |
| 90 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.70121955 |
| 91 | positive regulation of mast cell activation (GO:0033005) | 2.69426777 |
| 92 | myeloid dendritic cell activation (GO:0001773) | 2.68690512 |
| 93 | B cell mediated immunity (GO:0019724) | 2.68110206 |
| 94 | regulation of T cell tolerance induction (GO:0002664) | 2.68019628 |
| 95 | T cell homeostasis (GO:0043029) | 2.67449235 |
| 96 | granulocyte activation (GO:0036230) | 2.66952959 |
| 97 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.66841367 |
| 98 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.66557869 |
| 99 | microglial cell activation (GO:0001774) | 2.66502244 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.66499139 |
| 101 | neutrophil mediated immunity (GO:0002446) | 2.66286277 |
| 102 | lymphocyte costimulation (GO:0031294) | 2.65923313 |
| 103 | megakaryocyte development (GO:0035855) | 2.65498822 |
| 104 | regulation of mast cell activation (GO:0033003) | 2.64890508 |
| 105 | positive regulation of type 2 immune response (GO:0002830) | 2.64359014 |
| 106 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.64232988 |
| 107 | positive regulation of interferon-alpha production (GO:0032727) | 2.64178499 |
| 108 | cellular response to interleukin-15 (GO:0071350) | 2.63390703 |
| 109 | negative regulation of interleukin-6 production (GO:0032715) | 2.60726181 |
| 110 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.59010571 |
| 111 | lymphocyte homeostasis (GO:0002260) | 2.58638246 |
| 112 | pinocytosis (GO:0006907) | 2.58527701 |
| 113 | negative regulation of B cell proliferation (GO:0030889) | 2.58480860 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 2.58297078 |
| 115 | response to type I interferon (GO:0034340) | 2.57948866 |
| 116 | * natural killer cell activation (GO:0030101) | 2.57264117 |
| 117 | B cell homeostasis (GO:0001782) | 2.56878799 |
| 118 | regulation of antigen processing and presentation (GO:0002577) | 2.56530349 |
| 119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55768182 |
| 120 | leukocyte degranulation (GO:0043299) | 2.55128764 |
| 121 | T cell receptor signaling pathway (GO:0050852) | 2.54914245 |
| 122 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.54678795 |
| 123 | positive regulation of DNA recombination (GO:0045911) | 2.53514837 |
| 124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.52484767 |
| 125 | response to protozoan (GO:0001562) | 2.52071237 |
| 126 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.51612298 |
| 127 | respiratory burst (GO:0045730) | 2.51509423 |
| 128 | type I interferon signaling pathway (GO:0060337) | 2.51198871 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.51198871 |
| 130 | regulation of necroptotic process (GO:0060544) | 2.49798674 |
| 131 | establishment of endothelial barrier (GO:0061028) | 2.49350939 |
| 132 | regulation of response to interferon-gamma (GO:0060330) | 2.48714132 |
| 133 | definitive hemopoiesis (GO:0060216) | 2.48126598 |
| 134 | macrophage activation involved in immune response (GO:0002281) | 2.47840103 |
| 135 | mast cell activation (GO:0045576) | 2.46732435 |
| 136 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.45861823 |
| 137 | positive regulation of B cell mediated immunity (GO:0002714) | 2.45861823 |
| 138 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.43598500 |
| 139 | cellular response to zinc ion (GO:0071294) | 2.43499496 |
| 140 | myeloid dendritic cell differentiation (GO:0043011) | 2.42514537 |
| 141 | myeloid cell activation involved in immune response (GO:0002275) | 2.41912372 |
| 142 | protein localization to kinetochore (GO:0034501) | 2.37566585 |
| 143 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.36933151 |
| 144 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.36098434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.25363022 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.13799635 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.03602866 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.97175808 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.82549080 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.79953140 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.34321546 |
| 8 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.12372294 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02581339 |
| 10 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.84164611 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.74416570 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60079552 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.58797996 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.54345055 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.51793479 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51272497 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51111655 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.48791995 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.46111148 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.40333511 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38397987 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.35328051 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34813676 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.27944508 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.21871903 |
| 26 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18998598 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.16890234 |
| 28 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13492932 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.07519120 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07158053 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03854793 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03366705 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03060212 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96509191 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92665921 |
| 36 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.88128642 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79754180 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75912828 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73289152 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69345032 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.68950100 |
| 42 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.66440480 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65102339 |
| 44 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.63895082 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58913282 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56789695 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54146924 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52989816 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48953903 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.45013859 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40885843 |
| 52 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.39615050 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38761010 |
| 54 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37581755 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37399357 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36712304 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36553198 |
| 58 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.36510438 |
| 59 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.35125427 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33207591 |
| 61 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.32342162 |
| 62 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.32304591 |
| 63 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28533024 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28213071 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27350973 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26853458 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24043037 |
| 68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23943311 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23363290 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19879850 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19263759 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19061211 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14922485 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13197966 |
| 75 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10094470 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08011051 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07865449 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05057459 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03807568 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03429529 |
| 81 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03192068 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02940074 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02781162 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01538257 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00749827 |
| 86 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98243154 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97921422 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97287210 |
| 89 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95654515 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94909527 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94226774 |
| 92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93540375 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90812069 |
| 94 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90284797 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90246325 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88992940 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88964140 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.88350739 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87386497 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87267069 |
| 101 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86936454 |
| 102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84856681 |
| 103 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84013728 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83741634 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.82807630 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82038516 |
| 107 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.78046145 |
| 108 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.78046145 |
| 109 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.78046145 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77948224 |
| 111 | GATA1_22025678_ChIP-Seq_K562_Human | 0.77617852 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77493164 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.77150806 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75707102 |
| 115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74966828 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74526755 |
| 117 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.74181114 |
| 118 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.72898499 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72371302 |
| 120 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71977053 |
| 121 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.71721922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.56079226 |
| 2 | MP0005671_abnormal_response_to | 2.89652797 |
| 3 | MP0000685_abnormal_immune_system | 2.87519553 |
| 4 | MP0001800_abnormal_humoral_immune | 2.87283251 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.75567557 |
| 6 | MP0003436_decreased_susceptibility_to | 2.75454813 |
| 7 | MP0003303_peritoneal_inflammation | 2.72173116 |
| 8 | MP0005387_immune_system_phenotype | 2.67741305 |
| 9 | MP0001790_abnormal_immune_system | 2.67741305 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.61015937 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.56500851 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.50327152 |
| 13 | MP0005451_abnormal_body_composition | 2.42267992 |
| 14 | MP0006082_CNS_inflammation | 2.39700590 |
| 15 | MP0002723_abnormal_immune_serum | 2.37355481 |
| 16 | MP0009785_altered_susceptibility_to | 2.37162639 |
| 17 | * MP0002420_abnormal_adaptive_immunity | 2.36654016 |
| 18 | * MP0001819_abnormal_immune_cell | 2.34810742 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.29325977 |
| 20 | MP0005025_abnormal_response_to | 2.26364898 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 2.23711496 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.22530111 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.12780501 |
| 24 | MP0002419_abnormal_innate_immunity | 2.09169843 |
| 25 | MP0002405_respiratory_system_inflammati | 2.07164126 |
| 26 | * MP0000716_abnormal_immune_system | 2.05421745 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.98583259 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.96994941 |
| 29 | MP0009278_abnormal_bone_marrow | 1.94477329 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.93889110 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.93776378 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.91018078 |
| 33 | * MP0002722_abnormal_immune_system | 1.90719423 |
| 34 | * MP0004808_abnormal_hematopoietic_stem | 1.87468760 |
| 35 | MP0004947_skin_inflammation | 1.85221408 |
| 36 | MP0008260_abnormal_autophagy | 1.83488632 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.81528907 |
| 38 | MP0001873_stomach_inflammation | 1.79042008 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.77370541 |
| 40 | * MP0002429_abnormal_blood_cell | 1.76406895 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.68430120 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.68430120 |
| 43 | MP0002006_tumorigenesis | 1.67442729 |
| 44 | MP0001853_heart_inflammation | 1.61438443 |
| 45 | MP0000490_abnormal_crypts_of | 1.57914706 |
| 46 | * MP0001845_abnormal_inflammatory_respons | 1.52553214 |
| 47 | MP0004510_myositis | 1.46191383 |
| 48 | MP0003448_altered_tumor_morphology | 1.46041763 |
| 49 | MP0008057_abnormal_DNA_replication | 1.45448641 |
| 50 | MP0000858_altered_metastatic_potential | 1.45096066 |
| 51 | MP0003724_increased_susceptibility_to | 1.44965805 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.39213867 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.37379827 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.34417316 |
| 55 | MP0009840_abnormal_foam_cell | 1.32277407 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.31118844 |
| 57 | MP0010307_abnormal_tumor_latency | 1.27034530 |
| 58 | MP0002933_joint_inflammation | 1.26558619 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 1.26505750 |
| 60 | MP0003075_altered_response_to | 1.22599642 |
| 61 | MP0003866_abnormal_defecation | 1.22549473 |
| 62 | MP0005310_abnormal_salivary_gland | 1.20208355 |
| 63 | MP0003828_pulmonary_edema | 1.19028636 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.17662515 |
| 65 | MP0005023_abnormal_wound_healing | 1.13974510 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.12046951 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.10856077 |
| 68 | MP0003077_abnormal_cell_cycle | 1.10215773 |
| 69 | MP0008004_abnormal_stomach_pH | 1.10153801 |
| 70 | MP0002019_abnormal_tumor_incidence | 1.09116424 |
| 71 | MP0004883_abnormal_blood_vessel | 1.06263474 |
| 72 | MP0004264_abnormal_extraembryonic_tissu | 1.05742110 |
| 73 | MP0005164_abnormal_response_to | 1.05293101 |
| 74 | MP0008469_abnormal_protein_level | 1.02501581 |
| 75 | MP0005166_decreased_susceptibility_to | 1.01084897 |
| 76 | MP0000343_altered_response_to | 0.99711996 |
| 77 | MP0008961_abnormal_basal_metabolism | 0.99686236 |
| 78 | MP0005174_abnormal_tail_pigmentation | 0.99363661 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.98652689 |
| 80 | MP0006054_spinal_hemorrhage | 0.96333024 |
| 81 | MP0003693_abnormal_embryo_hatching | 0.95955489 |
| 82 | MP0001851_eye_inflammation | 0.93966625 |
| 83 | MP0004957_abnormal_blastocyst_morpholog | 0.92697495 |
| 84 | MP0002254_reproductive_system_inflammat | 0.91446885 |
| 85 | MP0010094_abnormal_chromosome_stability | 0.91141698 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.90452442 |
| 87 | MP0003091_abnormal_cell_migration | 0.88116602 |
| 88 | MP0000604_amyloidosis | 0.86383450 |
| 89 | MP0000350_abnormal_cell_proliferation | 0.85520543 |
| 90 | MP0002132_abnormal_respiratory_system | 0.84762645 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.81108096 |
| 92 | MP0009763_increased_sensitivity_to | 0.80978214 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.80502907 |
| 94 | MP0003111_abnormal_nucleus_morphology | 0.79335334 |
| 95 | MP0000313_abnormal_cell_death | 0.78685111 |
| 96 | MP0008007_abnormal_cellular_replicative | 0.77570824 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.77492709 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.77470471 |
| 99 | MP0003279_aneurysm | 0.77263517 |
| 100 | MP0002009_preneoplasia | 0.76695910 |
| 101 | MP0001663_abnormal_digestive_system | 0.76175444 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.75941477 |
| 103 | MP0003984_embryonic_growth_retardation | 0.74419457 |
| 104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74154937 |
| 105 | MP0002088_abnormal_embryonic_growth/wei | 0.73901778 |
| 106 | MP0002086_abnormal_extraembryonic_tissu | 0.73765646 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.73662659 |
| 108 | MP0005390_skeleton_phenotype | 0.73376632 |
| 109 | MP0003045_fibrosis | 0.73262178 |
| 110 | MP0004381_abnormal_hair_follicle | 0.72852478 |
| 111 | MP0002332_abnormal_exercise_endurance | 0.69069743 |
| 112 | MP0003690_abnormal_glial_cell | 0.68355657 |
| 113 | MP0000249_abnormal_blood_vessel | 0.67735938 |
| 114 | MP0001849_ear_inflammation | 0.67364582 |
| 115 | MP0000477_abnormal_intestine_morphology | 0.65855893 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 0.65616202 |
| 117 | MP0005621_abnormal_cell_physiology | 0.64944590 |
| 118 | MP0003795_abnormal_bone_structure | 0.64916319 |
| 119 | MP0005409_darkened_coat_color | 0.64591836 |
| 120 | MP0009764_decreased_sensitivity_to | 0.64002185 |
| 121 | MP0005380_embryogenesis_phenotype | 0.63748824 |
| 122 | MP0001672_abnormal_embryogenesis/_devel | 0.63748824 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.63305793 |
| 124 | MP0001243_abnormal_dermal_layer | 0.63195353 |
| 125 | MP0002796_impaired_skin_barrier | 0.61641830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent viral infections (HP:0004429) | 4.23627207 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.09607574 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.04511571 |
| 4 | Myositis (HP:0100614) | 3.95628596 |
| 5 | Recurrent fungal infections (HP:0002841) | 3.95387048 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.92282264 |
| 7 | Cellulitis (HP:0100658) | 3.65837603 |
| 8 | T lymphocytopenia (HP:0005403) | 3.63469250 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.60566076 |
| 10 | Abnormality of T cell number (HP:0011839) | 3.49309055 |
| 11 | Nasal polyposis (HP:0100582) | 3.44671824 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.41080551 |
| 13 | IgM deficiency (HP:0002850) | 3.39350029 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.36349434 |
| 15 | Orchitis (HP:0100796) | 3.24632324 |
| 16 | Abnormality of the fingertips (HP:0001211) | 3.18379498 |
| 17 | Recurrent bronchitis (HP:0002837) | 3.16405276 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.16125646 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.15167588 |
| 20 | Abnormality of the nasal mucosa (HP:0000433) | 3.13497100 |
| 21 | Abnormality of T cells (HP:0002843) | 3.12658114 |
| 22 | Meningitis (HP:0001287) | 3.06971695 |
| 23 | Agammaglobulinemia (HP:0004432) | 3.05394164 |
| 24 | Chronic otitis media (HP:0000389) | 3.03915577 |
| 25 | Spontaneous hematomas (HP:0007420) | 2.96609539 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 2.95596123 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.95596123 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.89804743 |
| 29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.89804743 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 2.89804743 |
| 31 | Inflammation of the large intestine (HP:0002037) | 2.87384790 |
| 32 | Vasculitis (HP:0002633) | 2.85885650 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 2.83414867 |
| 34 | Urticaria (HP:0001025) | 2.83319604 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.82842611 |
| 36 | Combined immunodeficiency (HP:0005387) | 2.81922089 |
| 37 | Pustule (HP:0200039) | 2.73458628 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.70436852 |
| 39 | Recurrent skin infections (HP:0001581) | 2.70003871 |
| 40 | Colitis (HP:0002583) | 2.67133668 |
| 41 | B lymphocytopenia (HP:0010976) | 2.63023838 |
| 42 | Abnormality of B cell number (HP:0010975) | 2.63023838 |
| 43 | Eosinophilia (HP:0001880) | 2.61213072 |
| 44 | Petechiae (HP:0000967) | 2.57887206 |
| 45 | Obstructive lung disease (HP:0006536) | 2.57069528 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.57069528 |
| 47 | Leukocytosis (HP:0001974) | 2.54637778 |
| 48 | Periodontitis (HP:0000704) | 2.53376008 |
| 49 | Thrombocytosis (HP:0001894) | 2.52879524 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.52707182 |
| 51 | Thyroiditis (HP:0100646) | 2.51223267 |
| 52 | Verrucae (HP:0200043) | 2.49807321 |
| 53 | Papilloma (HP:0012740) | 2.49807321 |
| 54 | Retrobulbar optic neuritis (HP:0100654) | 2.49510886 |
| 55 | Optic neuritis (HP:0100653) | 2.49510886 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.49347156 |
| 57 | Chest pain (HP:0100749) | 2.48993732 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.43652369 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.43438826 |
| 60 | Lymphopenia (HP:0001888) | 2.42197552 |
| 61 | Amyloidosis (HP:0011034) | 2.40672212 |
| 62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36684890 |
| 63 | Abnormality of macrophages (HP:0004311) | 2.35154259 |
| 64 | Gingivitis (HP:0000230) | 2.34493827 |
| 65 | Loss of speech (HP:0002371) | 2.31779434 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31578950 |
| 67 | Increased IgE level (HP:0003212) | 2.30910196 |
| 68 | Hematochezia (HP:0002573) | 2.30285946 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.28032526 |
| 70 | Granulocytopenia (HP:0001913) | 2.24622886 |
| 71 | Osteomyelitis (HP:0002754) | 2.23244105 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.23046728 |
| 73 | Encephalitis (HP:0002383) | 2.22350310 |
| 74 | Arterial thrombosis (HP:0004420) | 2.21585579 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.21232911 |
| 76 | Increased serum ferritin (HP:0003281) | 2.20724424 |
| 77 | Severe combined immunodeficiency (HP:0004430) | 2.20493239 |
| 78 | Episodic fever (HP:0001954) | 2.18242231 |
| 79 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.17611587 |
| 80 | Hemoptysis (HP:0002105) | 2.15993035 |
| 81 | Increased IgM level (HP:0003496) | 2.15462307 |
| 82 | Stomatitis (HP:0010280) | 2.13679969 |
| 83 | Cheilitis (HP:0100825) | 2.10770925 |
| 84 | Slow saccadic eye movements (HP:0000514) | 2.10677869 |
| 85 | Polycythemia (HP:0001901) | 2.08888211 |
| 86 | Epistaxis (HP:0000421) | 2.08445654 |
| 87 | Emphysema (HP:0002097) | 2.07861638 |
| 88 | Abnormal platelet volume (HP:0011876) | 2.07512429 |
| 89 | Syringomyelia (HP:0003396) | 2.06978339 |
| 90 | Spinal cord lesions (HP:0100561) | 2.06978339 |
| 91 | Abnormality of the peritoneum (HP:0002585) | 2.06004169 |
| 92 | IgG deficiency (HP:0004315) | 2.04843958 |
| 93 | Fatigue (HP:0012378) | 2.04807195 |
| 94 | Gastrointestinal stroma tumor (HP:0100723) | 2.03253079 |
| 95 | Gingival bleeding (HP:0000225) | 2.02817680 |
| 96 | IgA deficiency (HP:0002720) | 2.02172755 |
| 97 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00737123 |
| 98 | Vacuolated lymphocytes (HP:0001922) | 2.00515173 |
| 99 | Autoimmune hemolytic anemia (HP:0001890) | 1.99466512 |
| 100 | Lymphoma (HP:0002665) | 1.98723979 |
| 101 | Hypertensive crisis (HP:0100735) | 1.97525475 |
| 102 | Increased density of long bones (HP:0006392) | 1.96472886 |
| 103 | Hypochromic anemia (HP:0001931) | 1.96151702 |
| 104 | Anorexia (HP:0002039) | 1.95423563 |
| 105 | Purpura (HP:0000979) | 1.94828261 |
| 106 | Glomerulopathy (HP:0100820) | 1.94716794 |
| 107 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.94649709 |
| 108 | Absent frontal sinuses (HP:0002688) | 1.94412602 |
| 109 | Impaired platelet aggregation (HP:0003540) | 1.94402825 |
| 110 | Abnormal platelet function (HP:0011869) | 1.94402825 |
| 111 | Skin ulcer (HP:0200042) | 1.92561256 |
| 112 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91830095 |
| 113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91830095 |
| 114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91830095 |
| 115 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90951021 |
| 116 | Mucopolysacchariduria (HP:0008155) | 1.90951021 |
| 117 | Restrictive lung disease (HP:0002091) | 1.89826254 |
| 118 | Hepatosplenomegaly (HP:0001433) | 1.87430168 |
| 119 | Chronic diarrhea (HP:0002028) | 1.85923365 |
| 120 | Pulmonary embolism (HP:0002204) | 1.84621205 |
| 121 | Dilatation of the ascending aorta (HP:0005111) | 1.84502024 |
| 122 | Polygenic inheritance (HP:0010982) | 1.84306096 |
| 123 | Myocardial infarction (HP:0001658) | 1.83490969 |
| 124 | Gangrene (HP:0100758) | 1.83415693 |
| 125 | Malnutrition (HP:0004395) | 1.81944445 |
| 126 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.81885278 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 1.81885278 |
| 128 | Recurrent lower respiratory tract infections (HP:0002783) | 1.81194689 |
| 129 | Premature loss of primary teeth (HP:0006323) | 1.80804345 |
| 130 | Abnormality of the pleura (HP:0002103) | 1.80382018 |
| 131 | Viral hepatitis (HP:0006562) | 1.79553015 |
| 132 | Abnormality of the prostate (HP:0008775) | 1.79212869 |
| 133 | Spondylolisthesis (HP:0003302) | 1.78067287 |
| 134 | Acute myeloid leukemia (HP:0004808) | 1.72769279 |
| 135 | Sepsis (HP:0100806) | 1.72514410 |
| 136 | Keratoconjunctivitis sicca (HP:0001097) | 1.71615351 |
| 137 | Hypergammaglobulinemia (HP:0010702) | 1.69936898 |
| 138 | Peritonitis (HP:0002586) | 1.69178344 |
| 139 | Cerebral aneurysm (HP:0004944) | 1.68629844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.29723633 |
| 2 | PRPF4B | 3.71165687 |
| 3 | CDK12 | 3.67738469 |
| 4 | ERN1 | 3.22709913 |
| 5 | STK10 | 2.92121325 |
| 6 | GRK6 | 2.68225441 |
| 7 | MAP3K10 | 2.64240900 |
| 8 | TXK | 2.52311360 |
| 9 | JAK3 | 2.23377606 |
| 10 | TYK2 | 2.22683158 |
| 11 | CSF1R | 2.13759675 |
| 12 | EEF2K | 2.13235307 |
| 13 | TGFBR2 | 2.06906008 |
| 14 | ZAP70 | 1.95576005 |
| 15 | BLK | 1.86862844 |
| 16 | TRIB3 | 1.83845236 |
| 17 | ITK | 1.80095057 |
| 18 | MAP3K3 | 1.74749541 |
| 19 | MAP3K14 | 1.68494350 |
| 20 | TBK1 | 1.62641458 |
| 21 | FGFR3 | 1.61124238 |
| 22 | BTK | 1.59966069 |
| 23 | SMG1 | 1.59407368 |
| 24 | KIT | 1.57853532 |
| 25 | TAOK2 | 1.57224525 |
| 26 | CSK | 1.56655173 |
| 27 | PKN2 | 1.55012607 |
| 28 | IRAK4 | 1.46722157 |
| 29 | JAK1 | 1.45898109 |
| 30 | IKBKB | 1.42160148 |
| 31 | LRRK2 | 1.38121170 |
| 32 | IKBKE | 1.37954562 |
| 33 | SYK | 1.36874095 |
| 34 | HCK | 1.34660590 |
| 35 | FGR | 1.34153852 |
| 36 | MAP3K1 | 1.33824586 |
| 37 | RPS6KA4 | 1.33396258 |
| 38 | KSR2 | 1.33334461 |
| 39 | RIPK4 | 1.33293794 |
| 40 | SIK2 | 1.28354182 |
| 41 | TEC | 1.23952091 |
| 42 | LCK | 1.22211248 |
| 43 | MAP3K11 | 1.20139240 |
| 44 | PIM1 | 1.19267066 |
| 45 | BMPR2 | 1.18257459 |
| 46 | EPHB1 | 1.15330671 |
| 47 | MATK | 1.08720780 |
| 48 | MAP2K3 | 1.08492648 |
| 49 | NEK2 | 1.07468393 |
| 50 | FGFR4 | 1.07291152 |
| 51 | IRAK2 | 1.07177498 |
| 52 | CLK1 | 1.05869832 |
| 53 | CDC42BPA | 1.05050452 |
| 54 | CHUK | 1.02667269 |
| 55 | STK4 | 1.00104060 |
| 56 | MARK3 | 0.98051448 |
| 57 | CDK4 | 0.97259877 |
| 58 | ICK | 0.94830838 |
| 59 | IRAK1 | 0.94754151 |
| 60 | TTN | 0.92727651 |
| 61 | PRKD2 | 0.86266556 |
| 62 | NLK | 0.80575548 |
| 63 | PTK6 | 0.79650435 |
| 64 | MAP3K13 | 0.79596643 |
| 65 | HIPK2 | 0.78692452 |
| 66 | PDPK1 | 0.78457264 |
| 67 | LYN | 0.78233062 |
| 68 | IRAK3 | 0.77700363 |
| 69 | PAK4 | 0.77494409 |
| 70 | FLT3 | 0.77192475 |
| 71 | YES1 | 0.76702828 |
| 72 | TRPM7 | 0.74998213 |
| 73 | MAPK7 | 0.74632504 |
| 74 | SIK3 | 0.74317530 |
| 75 | PDK1 | 0.73322160 |
| 76 | FES | 0.73026109 |
| 77 | NEK9 | 0.72693465 |
| 78 | CDK6 | 0.72287394 |
| 79 | TAOK3 | 0.71646229 |
| 80 | MST4 | 0.71030907 |
| 81 | JAK2 | 0.70215871 |
| 82 | MOS | 0.69121555 |
| 83 | STK3 | 0.67884991 |
| 84 | PIM2 | 0.67197049 |
| 85 | ALK | 0.65739947 |
| 86 | MAP3K7 | 0.65394056 |
| 87 | STK24 | 0.65108320 |
| 88 | MAP3K6 | 0.63372025 |
| 89 | MAP3K2 | 0.62606353 |
| 90 | RPS6KB2 | 0.61130125 |
| 91 | PRKG2 | 0.59484726 |
| 92 | MAP3K8 | 0.59356015 |
| 93 | CDK7 | 0.58614272 |
| 94 | KDR | 0.57775483 |
| 95 | TGFBR1 | 0.57408714 |
| 96 | RIPK1 | 0.57222034 |
| 97 | NME2 | 0.55538509 |
| 98 | MAPK12 | 0.53247005 |
| 99 | DMPK | 0.52391837 |
| 100 | PRKCQ | 0.52313937 |
| 101 | CAMK1D | 0.51040545 |
| 102 | BRD4 | 0.50969257 |
| 103 | RPS6KL1 | 0.50786971 |
| 104 | RPS6KC1 | 0.50786971 |
| 105 | MAPK11 | 0.50629320 |
| 106 | TAOK1 | 0.50055684 |
| 107 | MAPKAPK2 | 0.50035641 |
| 108 | PDGFRB | 0.49077656 |
| 109 | MELK | 0.48132055 |
| 110 | SIK1 | 0.45101990 |
| 111 | TNK2 | 0.43811079 |
| 112 | CDK9 | 0.43171402 |
| 113 | PRKCH | 0.42404027 |
| 114 | BMX | 0.41562552 |
| 115 | MTOR | 0.41277473 |
| 116 | ADRBK2 | 0.40737806 |
| 117 | SGK3 | 0.40411069 |
| 118 | RPS6KA2 | 0.39307827 |
| 119 | CDC7 | 0.39111476 |
| 120 | MAPK4 | 0.38986244 |
| 121 | GRK7 | 0.38977195 |
| 122 | EPHA3 | 0.38959139 |
| 123 | FYN | 0.38806899 |
| 124 | EGFR | 0.38116738 |
| 125 | TESK2 | 0.36982348 |
| 126 | KSR1 | 0.36471937 |
| 127 | MARK2 | 0.35639292 |
| 128 | SCYL2 | 0.35235605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.17852542 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55405615 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.45068174 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.33823269 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10889065 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10313702 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09942159 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.04890191 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.00297700 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.96393113 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.95790776 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.90895469 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84422437 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.77823595 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.67620303 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66064579 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62662344 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.61583558 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61361945 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55713421 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53914688 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53379451 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53368645 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.49460426 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.47861176 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.44948694 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.42270158 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.41842092 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.41691283 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36346975 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35521663 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.34903083 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33690107 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.33661533 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.32235363 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28837676 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.27159288 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24968570 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.24206008 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.22406948 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.20046255 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.18014972 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14965651 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12390265 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.09814082 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.08973760 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.07874264 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.06951273 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02859816 |
| 50 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01341005 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00632192 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99473600 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.98444726 |
| 54 | DNA replication_Homo sapiens_hsa03030 | 0.98142448 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.95544543 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.95032734 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93895253 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92890558 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89826129 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89408615 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.86362473 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85709333 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84743462 |
| 64 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83045655 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82978150 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80834099 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80316698 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79457229 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79181425 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.78413315 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75815775 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74445424 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74105575 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73900289 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72453842 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72304500 |
| 77 | Cell cycle_Homo sapiens_hsa04110 | 0.71307090 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.69573221 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68743962 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65911165 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65454123 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62728600 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61637772 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60216939 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59848806 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59709330 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58872270 |
| 88 | Ribosome_Homo sapiens_hsa03010 | 0.56093370 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55787622 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.55556428 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.54399318 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.54150746 |
| 93 | Adherens junction_Homo sapiens_hsa04520 | 0.53683651 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.53103187 |
| 95 | Mismatch repair_Homo sapiens_hsa03430 | 0.52959646 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52944342 |
| 97 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52891321 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52477443 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.51986531 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.51497426 |
| 101 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50919828 |
| 102 | Spliceosome_Homo sapiens_hsa03040 | 0.50216493 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50051744 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47957304 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47954724 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47867906 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46034277 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46012304 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.45968282 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45860857 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44957495 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44688441 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43779993 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42860511 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.40231807 |
| 116 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40014136 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.39415241 |
| 118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39218175 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38143369 |
| 120 | RNA transport_Homo sapiens_hsa03013 | 0.37788447 |

